Melatonin Supplementation Alleviates Bone Mineral Density Decline and Circulating Oxidative Stress in Iron‐Overloaded Thalassemia Patients
Journal of Pineal Research · 2025-04 · 77 (3)
DOI: 10.1111/jpi.70055 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pineal Research, online erschienen am 06.05.2025. Verfasst von Pokpong Piriyakhuntorn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Melatonin, Oxidative Stress, Bone Density, Thalassemia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: This research was supported by Fundamental Fund 2022, Chiang Mai University (Grant number FF65/040), a research grant from the Faculty of Medicine, Chiang Mai….
Abstract (Originalsprache)
Thalassemia patients often exhibit low bone mineral density (BMD). The iron overload associated with thalassemia elevates oxidative stress levels, leading to reduced BMD. Melatonin improves BMD in postmenopausal osteopenia, however, its effect on BMD in thalassemia patients with iron overload has not been investigated. A randomized controlled study was conducted at Hematology Clinic, Faculty of Medicine, Chiang Mai University. Thalassemia patients with osteopenia and iron overloaded condition, as indicated by BMD Z‐score 500 μg/L were recruited in this study. Patients were randomized to receive either melatonin 20 mg/day or placebo at bedtime for 12 months. BMD was re‐evaluated 12 months after interventions. Bone turnover markers (BTM), malondialdehyde (MDA as an oxidative stress marker), and pain scores were assessed at baseline, 6, and 12 months. The outcomes, including BMD, BTM, MDA, and pain scores, were evaluated in all patients. Forty‐one thalassemia patients (18 males) were enrolled in the study and randomly assigned to either the melatonin group ( n = 21) or the placebo group ( n = 20). Characteristics of patients were not differences between groups. Mean age was 30.8 ± 6.2 years old. Thirty‐three patients (80.4%) were transfusion‐dependent patients. At 12 months, mean BMD at l ‐spine in melatonin group was not significantly different from placebo group ( p = 0.069). However, l ‐spine BMD at 12 months in the melatonin group was significantly greater than baseline ( p = 0.029). Serum levels of P1NP and MDA were significantly reduced at 6 months compared to baseline following melatonin treatment. The melatonin group experienced a notable decrease in back pain scores after 12 months compared to the initial measurements. 20 mg daily melatonin supplementation for 12 months alleviated l ‐spine BMD loss in iron‐overloaded thalassemia with low BMD. Melatonin also significantly reduced circulating oxidative stress and mitigated back pain in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.
- Department of Oral Surgery, Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand.
Förderung
- This research was supported by Fundamental Fund 2022, Chiang Mai University (Grant number FF65/040), a research grant from the Faculty of Medicine, Chiang Mai…
Zitieren
APA
Piriyakhuntorn, P., Tantiworawit, A., Phimphilai, M., Kaewchur, T., Niprapan, P., Srivichit, B., Apaijai, N., Shinlapawittayatorn, K., Chattipakorn, N., & Chattipakorn, S. C. (2025). Melatonin Supplementation Alleviates Bone Mineral Density Decline and Circulating Oxidative Stress in Iron‐Overloaded Thalassemia Patients. Journal of Pineal Research, 77(3). https://doi.org/10.1111/jpi.70055
Vancouver
Piriyakhuntorn P, Tantiworawit A, Phimphilai M, Kaewchur T, Niprapan P, Srivichit B, et al. Melatonin Supplementation Alleviates Bone Mineral Density Decline and Circulating Oxidative Stress in Iron‐Overloaded Thalassemia Patients. Journal of Pineal Research. 2025;77(3). doi:10.1111/jpi.70055
BibTeX
@article{Piriyakhuntorn2025,
author = {Piriyakhuntorn, Pokpong and Tantiworawit, Adisak and Phimphilai, Mattabhorn and Kaewchur, Tawika and Niprapan, Piangrawee and Srivichit, Bhumrapee and Apaijai, Nattayaporn and Shinlapawittayatorn, Krekwit and Chattipakorn, Nipon and Chattipakorn, Siriporn C},
title = {Melatonin Supplementation Alleviates Bone Mineral Density Decline and Circulating Oxidative Stress in Iron‐Overloaded Thalassemia Patients},
journal = {Journal of Pineal Research},
year = {2025},
volume = {77},
number = {3},
doi = {10.1111/jpi.70055}
}
EUVIMED